logo BDSP

Base documentaire


  1. Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine.

    Article - En anglais

    Objectives-To investigate the reasons for poor uptake of immunisation (non-immunisation) and the possible side effects of measles, mumps, and rubella vaccine in a catch up immunisation campaign during a community outbreak of measles.

    Design-Descriptive study of reasons for non-immunisation and retrospective cohort study of side effects of the vaccine.

    Setting-Secondary schools in South Glamorgan

    Subjects-Random cluster sample of the parents of 500 children targeted but not immunised and a randomised sample of 2866 of the children targeted.

    Main outcome measure-Reasons for non-immunisation ; symptoms among immunised and non-immunised children.

    Results

    Immunisation coverage of the campaign was only 43.4% (7633/17 595).

    The practical problems experienced included non-return of consent forms (6698117595), refusal of immunisation (2061/10897 forms returned), and absence from school on day of immunisation (1203/8836 children with consent for immunisation).

    The most common reasons cited for non-immunisation were previous measles infection (145/232), previous immunisation against measles (781232), and concern about side effects (55/232).

    Conclusion-Many of the objections raised by parents could be overcome by emphasising that primary immunisation does not necessarily confer immunity and that diagnosis ofmeasles is unreliable.

    Measles, mumps, and rubella vaccine is safe in children aged 11-15.

    Mots-clés Pascal : Rougeole, Rubéole, Oreillons, Immunisation, Vaccination, Effet secondaire, Couverture, Prévention, Politique sanitaire, Cause, Refus, Grande Bretagne, Virose, Infection, Royaume Uni, Europe

    Mots-clés Pascal anglais : Measles, Rubella, Mumps, Immunization, Vaccination, Secondary effect, Coverage, Prevention, Health policy, Cause, Denial, Great Britain, Viral disease, Infection, United Kingdom, Europe

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0394487

    Code Inist : 002B05C02J. Création : 01/03/1996.